Article
Evaluating Large Language Models’ Performance in FDA Regulatory Science
2026-02-06
Abstract excerpt
<title>Abstract</title> <p> Background Clinical and population decision-making relies on the systematic evaluation of extensive regulatory evidence. The FDA drug reviews provide detailed information on clinical trial design, enrollment criteria, sample size, randomization, comparators, endpoints, and indications. However, extracting these data is resource-intensive and time-consuming. Generative Artificial Inte...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4e3717ca-7f86-56f5-8226-fa9bb6e1742d
- DOI
- 10.21203/rs.3.rs-8611276/v1
